Top ▲

GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

mitogen-activated protein kinase kinase 5

Click here for help

Target not currently curated in GtoImmuPdb

Target id: 2066

Nomenclature: mitogen-activated protein kinase kinase 5

Abbreviated Name: MEK5

Family: STE7 family

Contents:

Gene and Protein Information Click here for help
Species TM AA Chromosomal Location Gene Symbol Gene Name Reference
Human - 448 15q23 MAP2K5 mitogen-activated protein kinase kinase 5
Mouse - 448 9 B-C Map2k5 mitogen-activated protein kinase kinase 5
Rat - 448 8q24 Map2k5 mitogen activated protein kinase kinase 5
Previous and Unofficial Names Click here for help
dual specificity mitogen-activated protein kinase kinase 5 | MAP kinase kinase 5 | MAPKK5 | PRKMK5
Database Links Click here for help
Alphafold Q13163 (Hs), Q9WVS7 (Mm), Q62862 (Rn)
BRENDA 2.7.12.2
ChEMBL Target CHEMBL4948 (Hs)
Ensembl Gene ENSG00000137764 (Hs), ENSMUSG00000058444 (Mm), ENSRNOG00000007926 (Rn)
Entrez Gene 5607 (Hs), 23938 (Mm), 29568 (Rn)
Human Protein Atlas ENSG00000137764 (Hs)
KEGG Enzyme 2.7.12.2
KEGG Gene hsa:5607 (Hs), mmu:23938 (Mm), rno:29568 (Rn)
OMIM 602520 (Hs)
Pharos Q13163 (Hs)
RefSeq Nucleotide NM_001206804 (Hs), NM_011840 (Mm), NM_001033987 (Rn)
RefSeq Protein NP_002748 (Hs), NP_035970 (Mm), NP_001029159 (Rn)
UniProtKB Q13163 (Hs), Q9WVS7 (Mm), Q62862 (Rn)
Wikipedia MAP2K5 (Hs)
Selected 3D Structures Click here for help
Image of receptor 3D structure from RCSB PDB
Description:  Crystal Structure of the complex of human mitogen activated protein kinase kinase 5 phox domain (MAP2K5-phox) with human mitogen activated protein kinase kinase kinase 2 phox domain (MAP3K2-phox)
PDB Id:  2NPT
Resolution:  1.75Å
Species:  Human
References: 
Enzyme Reaction Click here for help
EC Number: 2.7.12.2

Download all structure-activity data for this target as a CSV file go icon to follow link

Inhibitors
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Value Parameter Reference
BIX02189 Small molecule or natural product Primary target of this compound Click here for species-specific activity table Hs Inhibition 8.8 pIC50 2
⤷ pIC50 8.8 (IC50 1.5x10-9 M) [2]
BIX02188 Small molecule or natural product Primary target of this compound Click here for species-specific activity table Hs Inhibition 8.4 pIC50 2
⤷ pIC50 8.4 (IC50 4.3x10-9 M) [2]
DiscoveRx KINOMEscan® screen Click here for help
A screen of 72 inhibitors against 456 human kinases. Quantitative data were derived using DiscoveRx KINOMEscan® platform.
http://www.discoverx.com/services/drug-discovery-development-services/kinase-profiling/kinomescan
Reference: 1,3
Key to terms and symbols Click column headers to sort
Target used in screen: MEK5
Ligand Sp. Type Action Value Parameter
PLX-4720 Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 9.8 pKd
foretinib Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 8.6 pKd
barasertib-hQPA Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 8.6 pKd
staurosporine Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 8.5 pKd
dasatinib Small molecule or natural product Approved drug Ligand has a PDB structure Immunopharmacology Ligand Hs Inhibitor Inhibition 8.5 pKd
lestaurtinib Small molecule or natural product Ligand has a PDB structure Immunopharmacology Ligand Hs Inhibitor Inhibition 8.1 pKd
PP-242 Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 8.1 pKd
Ki-20227 Small molecule or natural product Hs Inhibitor Inhibition 8.1 pKd
bosutinib Small molecule or natural product Approved drug Ligand has a PDB structure Immunopharmacology Ligand Hs Inhibitor Inhibition 8.1 pKd
dovitinib Small molecule or natural product Hs Inhibitor Inhibition 7.5 pKd
Displaying the top 10 most potent ligands  View all ligands in screen »

References

Show »

1. Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol, 29 (11): 1046-51. [PMID:22037378]

2. Tatake RJ, O'Neill MM, Kennedy CA, Wayne AL, Jakes S, Wu D, Kugler Jr SZ, Kashem MA, Kaplita P, Snow RJ. (2008) Identification of pharmacological inhibitors of the MEK5/ERK5 pathway. Biochem Biophys Res Commun, 377 (1): 120-5. [PMID:18834865]

3. Wodicka LM, Ciceri P, Davis MI, Hunt JP, Floyd M, Salerno S, Hua XH, Ford JM, Armstrong RC, Zarrinkar PP et al.. (2010) Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry. Chem Biol, 17 (11): 1241-9. [PMID:21095574]

How to cite this page

STE7 family: mitogen-activated protein kinase kinase 5. Last modified on 09/11/2016. Accessed on 27/10/2025. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetoimmunopharmacology.org/GRAC/ObjectDisplayForward?objectId=2066.